CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Update

CV Sciences, Inc. (OTCMKTS:CVSIGet Free Report) saw a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 59,400 shares, a growth of 506.1% from the October 31st total of 9,800 shares. Based on an average daily volume of 484,300 shares, the days-to-cover ratio is currently 0.1 days.

CV Sciences Stock Performance

OTCMKTS:CVSI remained flat at $0.04 on Wednesday. 311,154 shares of the company’s stock traded hands, compared to its average volume of 205,128. The firm has a market capitalization of $7.37 million, a PE ratio of -3.99 and a beta of 0.59. The stock has a fifty day moving average price of $0.05 and a two-hundred day moving average price of $0.05. CV Sciences has a 12 month low of $0.03 and a 12 month high of $0.10.

CV Sciences Company Profile

(Get Free Report)

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.

Featured Articles

Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.